NO993738L - 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi - Google Patents
2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemiInfo
- Publication number
- NO993738L NO993738L NO993738A NO993738A NO993738L NO 993738 L NO993738 L NO 993738L NO 993738 A NO993738 A NO 993738A NO 993738 A NO993738 A NO 993738A NO 993738 L NO993738 L NO 993738L
- Authority
- NO
- Norway
- Prior art keywords
- amino
- substituted pyridines
- arteriosclerosis
- treatment
- lipoproteinemia
- Prior art date
Links
- -1 2-amino-substituted pyridines Chemical class 0.000 title abstract 4
- 206010003210 Arteriosclerosis Diseases 0.000 title abstract 2
- 208000011775 arteriosclerosis disease Diseases 0.000 title abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 title 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000004679 hydroxides Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19704243A DE19704243A1 (de) | 1997-02-05 | 1997-02-05 | Neue 2-Amino-substituierte Pyridine |
| PCT/EP1998/000362 WO1998034920A1 (de) | 1997-02-05 | 1998-01-23 | 2-amino-substituierte pyridine verwendbar zur behandlung von arteriosklerose und hyperlipoproteinemie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993738D0 NO993738D0 (no) | 1999-08-02 |
| NO993738L true NO993738L (no) | 1999-09-17 |
Family
ID=7819326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993738A NO993738L (no) | 1997-02-05 | 1999-08-02 | 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973744A1 (de) |
| JP (1) | JP2001510478A (de) |
| KR (1) | KR20000070756A (de) |
| CN (1) | CN1252057A (de) |
| AU (1) | AU730109B2 (de) |
| BG (1) | BG103631A (de) |
| BR (1) | BR9807181A (de) |
| CA (1) | CA2279636A1 (de) |
| CZ (1) | CZ279299A3 (de) |
| DE (1) | DE19704243A1 (de) |
| HU (1) | HUP0001022A2 (de) |
| ID (1) | ID24208A (de) |
| IL (1) | IL131127A0 (de) |
| NO (1) | NO993738L (de) |
| NZ (1) | NZ337011A (de) |
| PL (1) | PL334899A1 (de) |
| SK (1) | SK104099A3 (de) |
| TR (1) | TR199901857T2 (de) |
| WO (1) | WO1998034920A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19845402B4 (de) * | 1998-10-02 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| OA12625A (en) | 2001-06-22 | 2006-06-12 | Pfizer Prod Inc | Pharmaceutical compositions of adsorbates of amorphous drug. |
| JP2004534812A (ja) | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | 薬物および中性ポリマーの分散物の医薬組成物 |
| DE60320940D1 (de) | 2002-02-01 | 2008-06-26 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
| WO2004082675A1 (en) | 2003-03-17 | 2004-09-30 | Japan Tobacco Inc. | Method for increasing the oral bioavailability of s-[2- ([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] 2-methylpropanethioate |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| BRPI0413277A (pt) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas |
| MXPA06003357A (es) | 2003-09-26 | 2006-06-08 | Japan Tobacco Inc | Metodo para inhibir la produccion de lipoproteina remanente. |
| DOP2005000123A (es) * | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | Inhibidores de cetp |
| WO2006032987A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Indoline compounds and their use in the treatment of arteriosclerosis |
| WO2006082518A1 (en) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
| US20100113473A1 (en) | 2008-10-30 | 2010-05-06 | Player Mark R | Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
-
1997
- 1997-02-05 DE DE19704243A patent/DE19704243A1/de not_active Withdrawn
-
1998
- 1998-01-23 CN CN98803916A patent/CN1252057A/zh active Pending
- 1998-01-23 ID IDW990821D patent/ID24208A/id unknown
- 1998-01-23 CA CA002279636A patent/CA2279636A1/en not_active Abandoned
- 1998-01-23 HU HU0001022A patent/HUP0001022A2/hu unknown
- 1998-01-23 NZ NZ337011A patent/NZ337011A/en unknown
- 1998-01-23 JP JP53369198A patent/JP2001510478A/ja active Pending
- 1998-01-23 CZ CZ992792A patent/CZ279299A3/cs unknown
- 1998-01-23 EP EP98904126A patent/EP0973744A1/de not_active Ceased
- 1998-01-23 IL IL13112798A patent/IL131127A0/xx unknown
- 1998-01-23 BR BR9807181-5A patent/BR9807181A/pt not_active IP Right Cessation
- 1998-01-23 WO PCT/EP1998/000362 patent/WO1998034920A1/de not_active Ceased
- 1998-01-23 KR KR1019997007015A patent/KR20000070756A/ko not_active Withdrawn
- 1998-01-23 SK SK1040-99A patent/SK104099A3/sk unknown
- 1998-01-23 TR TR1999/01857T patent/TR199901857T2/xx unknown
- 1998-01-23 AU AU62123/98A patent/AU730109B2/en not_active Ceased
- 1998-01-23 PL PL98334899A patent/PL334899A1/xx unknown
-
1999
- 1999-08-02 NO NO993738A patent/NO993738L/no not_active Application Discontinuation
- 1999-08-03 BG BG103631A patent/BG103631A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ279299A3 (cs) | 1999-11-17 |
| SK104099A3 (en) | 2000-01-18 |
| JP2001510478A (ja) | 2001-07-31 |
| BG103631A (en) | 2000-11-30 |
| IL131127A0 (en) | 2001-01-28 |
| AU6212398A (en) | 1998-08-26 |
| HUP0001022A2 (hu) | 2000-09-28 |
| AU730109B2 (en) | 2001-02-22 |
| PL334899A1 (en) | 2000-03-27 |
| CN1252057A (zh) | 2000-05-03 |
| EP0973744A1 (de) | 2000-01-26 |
| TR199901857T2 (xx) | 1999-10-21 |
| NO993738D0 (no) | 1999-08-02 |
| ID24208A (id) | 2000-07-13 |
| KR20000070756A (ko) | 2000-11-25 |
| CA2279636A1 (en) | 1998-08-13 |
| NZ337011A (en) | 2001-04-27 |
| BR9807181A (pt) | 2000-01-25 |
| DE19704243A1 (de) | 1998-08-06 |
| WO1998034920A1 (de) | 1998-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993738L (no) | 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi | |
| NO971269L (no) | 2-aryl-substituerte pyridiner | |
| GEP20032922B (en) | Benzoheterocycles and Their Use as MEK Inhibitors | |
| NO20062130L (no) | 4-(pyrazol-3-ylamino)pyrimidinderivater for anvendelse i behandling av kreft | |
| ATE301460T1 (de) | Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält. | |
| NO20074773L (no) | Caspaseinhibitorer og anvendelse derav | |
| NO983003L (no) | Vitronectin-reseptor-antagonister | |
| DE69919334D1 (de) | Phenylalaninderivate als inhibitoren von alpha4 integrinen | |
| MY112413A (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
| ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
| GEP20032869B (en) | Alpha -Ketoamide Inhibitors of 20S Proteasome, Pharmaceutical Preparations Containing the Same and Methods for Treatment | |
| AU7779900A (en) | Trifluoromethyl-substituted spirocyclic ketoenols | |
| ATE191218T1 (de) | Rapamycin-derivate als immunosuppressoren | |
| RU94044677A (ru) | Трехзамещенные фенильные производные, способ получения, фармацевтическая композиция | |
| NO20030301L (no) | Nye heteroarylderivater og anvendelse derav som farmasöytika | |
| ATE260910T1 (de) | 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep) | |
| AU5377698A (en) | Substituted pyrrolyl compounds for the treatment of inflammation | |
| NO20013680L (no) | Ketolidantibiotika | |
| WO1998042659A3 (en) | Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| GEP20002187B (en) | Carboxamide Derivatives of Pyrrolidine, Piperidine and Hexahydroazepine, Composition for the Treatment of Thrombosis Disorders Induced by Thrombocytes, Intermediate Compounds and Method for Their Preparation | |
| ATE267187T1 (de) | Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen | |
| DE69719358D1 (de) | Substituierte dihydrobenzofurane als pde-hemmstoffe | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| DE69927584D1 (de) | Pharmazeutische zubereitungen zur behandlung von magengeschwüren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |